Searched for
INDIAN PHARMA ALLIANCE
'Inflated medicine prices are daylight robbery': SC pulls up pharma companies over huge MRP-PTR gapSupreme Court on Tuesday questioned the wide gap between the price to retailer and MRP of some cancer medicines, calling inflated pricing a...- Economy’s swell, but reputation? Why India’s next growth story depends on how the world sees itIndia’s long-term economic prospects remain strong despite short-term geopolitical, currency and capital-flow challenges. As the country’s ...
- EQT Group plans to invest $50 billion in India by 2030: Jean Eric Salata, ChairmanSwedish buyout firm EQT plans to invest $50 billion in India over the next four years, roughly twice the $26 billion it has invested since ...
- Gland Pharma appoints Dr Reddy’s senior executive Deepak Sapra as CEOGland Pharma has appointed Deepak Sapra as its new chief executive officer, with his tenure set to begin on November 16, 2026, subject to h...
- Independence Day 2026: India, which once couldn't make smallpox vaccine, has now crossed a pharma milestone the world can't ignore2026 Independence Day: India's pharmaceutical industry marks a historic milestone with a new drug approval. This achievement reflects decad...
- IPA seeks to regularise 'legacy' drugsThe Indian Pharmaceutical Alliance seeks to regularize many drugs. These drugs have been marketed for years without central approval. Examp...
- Trump's 200% generic drug tariff threat puts $9.7 billion Indian pharma exports at risk; industry says reshoring not practicalUS President Trump's proposed tariffs on imported generic drugs will not immediately affect Indian drugmakers. Indian companies export sign...
- Trump's 100% tariff on pharma will not impact generic makers, says Indian Pharma AllianceDonald Trump's proposed 100% tariffs on patented drugs from October 2025 are unlikely to immediately impact Indian pharma exports, which pr...
- Sun Pharma, other drug cos say innovative products to contribute substantially in futureSun Pharma, India's largest drug maker, said it expects its innovative products to garner $1.5 billion in sales in the next 3-4 years.
- Expired, damaged drugs returned are not “supplies”; to save Rs 500 crore hitIndian Pharmaceutical Alliance had noted that the industry annually receives around Rs 3300 to Rs 5500 crore in expired or damaged stock an...
- Sun Pharma strikes distribution alliance with Mitsubishi Tanabe in JapanSun’s products are part of the long-listed and established prescription brands and includes Parlodel, Lamsil, Nitroderm and Lopressor.
- Bar-coding of drugs becomes mandatory to trace their originsBar-coding of mono cartons, which hold primary packs of drugs, will enable them to be traced back to the source, the ministry of commerce s...
- Indian drugmakers asks US Trade Representative body to restore faith in new trade policyIndian Pharma Alliance, a grouping of top domestic drugmakers, in its latest submission has urged the USTR to consider submissions of many ...
- Pfizer isolated in campaign against Indian patent regime, say Indian pharma allianceThe label is the lowest classification any country can find itself in on a US made rating scale for intellectual property protection.
- Government undecided over price cap on time-release drugsAnother official said the pharma department has taken up the issue with the ministry of health, which had set up the expert panel to list o...
- DCGI working on policy to respond to safety alerts by foreign regulatorsIndia's drug regulator is working on a policy on how to respond to safety alerts by foreign regulator on medicines manufactured by Indian co
- Pricing formula for patented drugs proposed for government buysA government panel proposes a mechanism that will apply only to medicines bought through public procurement and health insurance companies.
- Pharma pricing policy beneficial for consumers: Dilip G Shah, Indian Pharma AllianceIn an interview with ET Now, Dilip G Shah, Secretary-General, Indian Pharmaceutical Alliance, gives his views on the drug pricing policy. E...
- Alliance to foray into Indian pharma mktUK-BASED £14billion pharma, health and beauty retail major Alliance Boots is planning to make its entry in the Indian retail market.
- Alliance to foray into Indian pharma marketUK-based £14billion pharma, health and beauty retail major Alliance Boots is planning to make its entry in the Indian retail market. The co...
Load More
